Add to a list

Inactive Instrument

Tilray, Inc. Share Price Toronto S.E.

APHA

CA03765K1049

Last Transcript : Tilray, Inc.

Tilray Brands, Inc., Q4 2026 Earnings Call, Jul 28, 2026

07-29

More transcripts

Analysts' recommendations : Tilray, Inc.

04-02	Tilray Brands Shares Rise After Roth Capital Upgrade	MT
04-02	Roth Capital Upgrades Tilray Brands to Buy From Neutral, Price Target is $10	MT
29/09/25	Wall Street indexes climb as investors brush off government shutdown uncertainties	RE
09/04/25	Piper Sandler on Tilray: Canadian Cannabis Still Pressured, Guidance Lowered	MT
13/01/25	Piper Sandler Reviews Tilray's Q2	MT

More recommendations

News in other languages : Tilray, Inc.

04-23	Les États-Unis reclassent le cannabis dans une catégorie moins restrictive
04-23	Les USA reclassent le cannabis dans une catégorie moins restrictive
04-23	EEUU relaja normativa sobre la marihuana, un sector de 47.000 millones de dólares
04-23	Reclassement du cannabis aux Etats-Unis : les valeurs du secteur s'envolent en Bourse
12-18	MÄRKTE USA/Zinssenkungshoffnung und Micron geben Aktien Auftrieb

More news

Managers and Directors : Tilray, Inc.

Manager	Title	Age	Since
Irwin Simon CEO	Chief Executive Officer	67	30/04/2021
Carl Merton DFI	Director of Finance/CFO	57	30/04/2021
Roger Savell ADM	Chief Administrative Officer	64	30/03/2022

Director	Title	Age	Since
Irwin Simon CHM	Chairman	67	30/04/2021
David Clanachan BRD	Director/Board Member	64	29/04/2021
John Herhalt BRD	Director/Board Member	69	30/04/2021

More insiders

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services.

Employees

3,595

Sector

Pharmaceuticals

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	589M 506M 476M 435M 811M 55.85B 816M 5.65B 2.18B 28.54B 2.21B 2.16B 90.83B	P/E 2027 *	-8.53x	P/E 2028 *	-19.9x
Enterprise Value	562M 483M 455M 415M 775M 53.31B 779M 5.39B 2.08B 27.25B 2.11B 2.07B 86.7B	EV / Sales 2027 *	0.5x	EV / Sales 2028 *	0.47x
Free-Float	97.91%	Yield 2027 *	-	Yield 2028 *	-

09-03	Tilray Brands' Breckenridge Distillery Expands Distribution in New York, California	MT
09-02	Tilray Brands, Inc. And The Magnum Ice Cream Company Make Popsicle Hard Firecracker A Permanent Flavor	CI
08-20	Tilray Expands Global Cannabis Production Capacity to 275 Metric Tonnes	MT
08-20	Tilray Brands Increases Global Cannabis Cultivation Capacity To Approximately 275 Metric Tonnes	CI
08-18	BrewDog Unveils Its 2026 Advent Calendar Featuring New And Seasonal Brews	CI
08-17	Tilray Launching Cannabis Flower Products in The UK	MT
08-17	Tilray Brands Launches Cannabis Products in UK Through Lyphe	MT
08-17	Tilray Brands, Inc. Launches Tilray Medical-Branded Cannabis Medicines Direct-To-Patient Through Lyphe Clinic And Lyphe Dispensary In The UK	CI
08-11	Tilray Brands, Inc. Enters Energy Drink Distribution Agreement With Wolverhampton Wanderers Football Club	CI
08-06	Tilray Brands Launches Mollo Lite Blackberry Lemon Seltzer Multi-Pack	CI
07-29	Tilray Brands, Inc., Q4 2026 Earnings Call, Jul 28, 2026
07-28	Tilray Brands Fiscal Q4 Adjusted Earnings Fall, Revenue Rises	MT
07-28	Tilray Brands Reports Lower Adjusted Earnings, Higher Revenue for Fiscal Q4	MT

09-08	BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road	AQ
09-01	Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves	AQ
08-20	Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand	AQ
08-11	Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership	AQ
08-11	BrewDog Claims London's Summer Park Season with 'Park IPA'	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TILRAY, INC.	-5.59%	-15.99%	-	-	589M
ELI LILLY AND COMPANY	-2.21%	-3.11%	+52.16%	+91.64%	1,002B
JOHNSON & JOHNSON	-2.22%	-0.76%	+51.08%	+67.61%	649B
ABBVIE INC.	-2.99%	-4.31%	+18.59%	+66.94%	440B
ROCHE HOLDING AG	-0.23%	+0.03%	+29.51%	+37.57%	346B
NOVARTIS AG	-0.47%	-15.49%	+8.74%	+25.67%	263B
ASTRAZENECA PLC	-0.61%	-1.44%	-1.44%	+12.40%	250B
AMGEN INC.	-10.08%	-10.26%	+40.32%	+51.55%	213B
NOVO NORDISK A/S	-0.70%	-3.94%	-14.45%	-57.63%	201B
GILEAD SCIENCES, INC.	-2.88%	-2.19%	+26.54%	+92.95%	182B
Average	-1.88%	-2.06%	+23.45%	+43.19%	393.74B
Weighted average by Cap.	-0.50%	-2.39%	+32.79%	+57.63%

	2027 *	2028 *
Net sales	1.12B 965M 908M 829M 1.55B 106B 1.55B 10.76B 4.16B 54.41B 4.22B 4.12B 173B	1.18B 1.01B 952M 869M 1.62B 112B 1.63B 11.28B 4.36B 57.02B 4.42B 4.32B 181B
Net income	-61.49M -52.87M -49.74M -45.39M -84.71M -5.83B -85.14M -589M -228M -2.98B -231M -226M -9.48B	-26.86M -23.1M -21.73M -19.83M -37.01M -2.55B -37.2M -257M -99.61M -1.3B -101M -98.67M -4.14B
Net Debt	-26.8M -23.04M -21.68M -19.78M -36.91M -2.54B -37.1M -257M -99.36M -1.3B -101M -98.42M -4.13B	-39.31M -33.8M -31.79M -29.01M -54.15M -3.73B -54.43M -377M -146M -1.9B -148M -144M -6.06B

Tilray, Inc. Share Price Toronto S.E.

Stocks

APHA

CA03765K1049

Pharmaceuticals

Valuation : Tilray, Inc.

Latest news : Tilray, Inc.

Last Transcript : Tilray, Inc.

Analysts' recommendations : Tilray, Inc.

Press Releases : Tilray, Inc.

News in other languages : Tilray, Inc.

Quotes and Performance

Managers and Directors : Tilray, Inc.

Other Pharmaceuticals

Financials

Company Profile